ESHRE. Continuation rates for oral contraceptives and hormone replacement therapy

Author：

E-ISSN： 0268-1161|15|8|1865-1871

ISSN： 1460-2350

Source： Human Reproduction, Vol.15, Iss.8, 2000-08, pp. : 1865-1871

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

ESHRE. Screening before and during the use of oral contraceptives and hormone replacement therapy

Human Reproduction, Vol. 15, Iss. 2, 2000-02 ,pp. : 485-492

Oxford University Press

Access to resources Recommend Favorite

Gynaecologic challenging issues in the management of BRCA mutation carriers: oral contraceptives, prophylactic salpingo-oophorectomy and hormone replacement therapy

By Gadducci Angiolo Biglia Nicoletta Cosio Stefania Sismondi Piero Riccardo Genazzani Andrea

Gynecological Endocrinology, Vol. 26, Iss. 8, 2010-08 ,pp. : 568-577

Informa Healthcare

Access to resources Recommend Favorite

Hormone Replacement Therapy and Hypertension

By FELMEDEN DIRK C. LIP GREGORY Y. H.

Blood Pressure, Vol. 9, Iss. 5, 2000-12 ,pp. : 246-249

Informa Healthcare

Access to resources Recommend Favorite

Hormone replacement therapy and cancer

Gynecological Endocrinology, Vol. 15, Iss. 6, 2001-12 ,pp. : 453-465

Informa Healthcare

Access to resources Recommend Favorite

Hormone Replacement Therapy and Stroke

Current Vascular Pharmacology, Vol. 6, Iss. 2, 2008-04 ,pp. : 112-123

Bentham Science Publishers

Access to resources Recommend Favorite